In Vivo Therapeutics Holdings is a biotechnology company based in Cambridge, MA, specializing in developing innovative therapies for spinal cord injuries. The company focuses on research and development of novel treatments to address unmet medical needs in the field of neurosurgery.
With a commitment to advancing medical science, In Vivo Therapeutics Holdings collaborates with leading experts and institutions to bring cutting-edge solutions to patients with spinal cord injuries. Through a combination of scientific expertise and strategic partnerships, the company aims to improve patient outcomes and quality of life.
Generated from their business information